Guopan Yu
Guangdong Second Provincial General Hospital · Nanfang Hospital, Southern Medical University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Guopan Yu as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:48 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07813390 · Homoharringtonine, Lisaftoclax, and Azacitidine for AML After Venetoclax-Based Therapy FailureGuangdong Second Provincial General Hospital · enrolling by invitation · Acute Myeloid Leukemia (AML) · principal investigator
- Ph3NCT06810791 · HVA vs IA/DA or VA in the Treatment of ND HR-AMLNanfang Hospital, Southern Medical University · recruiting · Newly Diagnosed Acute Myeloid Leukemia With High Risk · principal investigator
- Ph4NCT06763666 · CLAG+VEN vs CLAG in the Treatment of Relapsed/Refractory AMLNanfang Hospital, Southern Medical University · not yet recruiting · Relapsed/Refractory AML · principal investigator
- Ph2/Ph3NCT03642236 · Combination of BTK Inhibitor Overcomes Drug-resistance in Refractory/Relapsed FLT3 Mutant AMLNanfang Hospital, Southern Medical University · unknown · FLT3-ITD Mutation, Acute Myeloid Leukemia, Brutons Tyrosine Kinase · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:48 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name in acute myeloid leukemia, ranked by citations from NIH iCite, fetched 2026-11-12 05:48 UTC. The ranking covers the 200 most relevant of 6 PubMed records, and a shared surname and initials can bring in a namesake. All 6 on PubMed
- 94 citationsRCR 3.2
- Venetoclax Combined with Azacitidine and Homoharringtonine in Relapsed/Refractory AML: A Multicenter, Phase 2 Trial.J Hematol Oncol · 202373 citationsRCR 7.1
- 27 citationsRCR 3.8
- Randomized, multicenter, parallel, open, phase 4 study to compare the efficacy and safety of rosuvastatin/amlodipine polypill versus atorvastatin/amlodipine polypill in hypertension patient with dyslipidemia.J Clin Hypertens (Greenwich) · 20234 citationsRCR 0.6
- Clinical significance of long noncoding RNA maternally expressed gene 3 in acute promyelocytic leukemia.Int J Lab Hematol · 20212 citationsRCR 0.1
- 0 citationsRCR 0.0